BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Furer V, Rondaan C, Heijstek MW, Agmon-levin N, van Assen S, Bijl M, Breedveld FC, D'amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2019;79:39-52. [DOI: 10.1136/annrheumdis-2019-215882] [Cited by in Crossref: 193] [Cited by in F6Publishing: 134] [Article Influence: 64.3] [Reference Citation Analysis]
Number Citing Articles
1 Gillet P. Is it safe to vaccinate rheumatic immunosuppressed patients? Yes, of course, but how? Therapie 2021;76:211-3. [PMID: 33339627 DOI: 10.1016/j.therap.2020.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Akmatov MK, Holstiege J, Steffen A, Bätzing J. Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis. Vaccine 2021;39:952-60. [PMID: 33451775 DOI: 10.1016/j.vaccine.2020.12.081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kiltz U, Celik A, Tsiami S, Baraliakos X, Andreica I, Kiefer D, Bühring B, Braun J. [How well are patients with inflammatory rheumatic diseases protected against measles?]. Z Rheumatol 2020;79:912-21. [PMID: 32930874 DOI: 10.1007/s00393-020-00874-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chiganer EH, Ochi BC, Lessa CF. Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross-sectional and comparative study. Adv Rheumatol 2021;61:46. [PMID: 34238387 DOI: 10.1186/s42358-021-00197-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chau CYC, Chow LLW, Sridhar S, Shih KC. Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders. Ophthalmol Ther 2021;10:201-9. [PMID: 33675508 DOI: 10.1007/s40123-021-00338-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Magro F, Rahier JF, Abreu C, MacMahon E, Hart A, van der Woude CJ, Gordon H, Adamina M, Viget N, Vavricka S, Kucharzik T, Leone S, Siegmund B, Danese S, Peyrin-Biroulet L. Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce. J Crohns Colitis. 2020;14:S798-S806. [PMID: 32722754 DOI: 10.1093/ecco-jcc/jjaa160] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
7 Tayer-Shifman OE, Bingham KS, Touma Z. Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management. Drugs Aging 2021. [PMID: 34913146 DOI: 10.1007/s40266-021-00911-0] [Reference Citation Analysis]
8 Martin C, Muls V, Brasseur C, Meric de Bellefon L, Lam Hoai XL, Vanderhilst J, Delforge M, Di Romana S. ImmunoStart: preparing patients for immunosuppression. Rheumatol Adv Pract 2021;5:rkab092. [PMID: 34909567 DOI: 10.1093/rap/rkab092] [Reference Citation Analysis]
9 Borba V, Malkova A, Basantsova N, Halpert G, Andreoli L, Tincani A, Amital H, Shoenfeld Y. Classical Examples of the Concept of the ASIA Syndrome. Biomolecules 2020;10:E1436. [PMID: 33053910 DOI: 10.3390/biom10101436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020;21:E3330. [PMID: 32397174 DOI: 10.3390/ijms21093330] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
11 Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open 2019;5:e001035. [PMID: 31565247 DOI: 10.1136/rmdopen-2019-001035] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
12 Kao CM, Hsieh TY, Lai KL. The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib. Arch Rheumatol 2021;36:305-7. [PMID: 34527938 DOI: 10.46497/ArchRheumatol.2021.8212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Blanchard-Rohner G. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide. Front Immunol 2021;12:711637. [PMID: 34408752 DOI: 10.3389/fimmu.2021.711637] [Reference Citation Analysis]
14 Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105221. [PMID: 34183155 DOI: 10.1016/j.jbspin.2021.105221] [Reference Citation Analysis]
15 Zhou Q, Zhou R, Yang H, Yang H. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis. Front Immunol 2021;12:733418. [PMID: 34603311 DOI: 10.3389/fimmu.2021.733418] [Reference Citation Analysis]
16 Welzel T, Benseler SM, Kuemmerle-Deschner JB. Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood. Front Immunol 2021;12:516427. [PMID: 33868220 DOI: 10.3389/fimmu.2021.516427] [Reference Citation Analysis]
17 Gerard AL, Goulenok T, Bahuaud M, Francois C, Aucouturier P, Moins-Teisserenc H, Batteux F, Papo T, Sacre K. Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE). Vaccine 2020;38:6859-63. [PMID: 32896468 DOI: 10.1016/j.vaccine.2020.08.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tummala R, Abreu G, Pineda L, Michaels MA, Kalyani RN, Furie RA, Morand EF. Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials. Lupus Sci Med 2021;8:e000464. [PMID: 33597205 DOI: 10.1136/lupus-2020-000464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Howland S, Deuring JJ, Zhou X, Chen Y, Mota LM, Ungaro RC. Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far? Curr Ther Res Clin Exp 2021;95:100639. [PMID: 34334801 DOI: 10.1016/j.curtheres.2021.100639] [Reference Citation Analysis]
20 Kahlmann V, Manansala M, Moor CC, Shahrara S, Wijsenbeek MS, Sweiss NJ. COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes. Curr Opin Pulm Med 2021;27:463-71. [PMID: 34397613 DOI: 10.1097/MCP.0000000000000812] [Reference Citation Analysis]
21 Sim JJL, Lim CC. Influenza Vaccination in Systemic Lupus Erythematosus: Efficacy, Effectiveness, Safety, Utilization, and Barriers. Am J Med 2021:S0002-9343(21)00608-2. [PMID: 34563493 DOI: 10.1016/j.amjmed.2021.08.038] [Reference Citation Analysis]
22 Jakimovski D, Weinstock-Guttman B, Ramanathan M, Dwyer MG, Zivadinov R. Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective. Vaccines (Basel) 2020;8:E50. [PMID: 32012815 DOI: 10.3390/vaccines8010050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
23 Tam LS, Tanaka Y, Handa R, Li Z, Lorenzo JP, Louthrenoo W, Hill C, Pile K, Robinson PC, Dans LF, Hsu LY, Lee SM, Cho J, Hasan ATMT, Salim B, Samreen S, Shaharir SS, Wong P, Chau J, Danda D, Haq SA. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic. Int J Rheum Dis 2021;24:733-45. [PMID: 33945214 DOI: 10.1111/1756-185X.14124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Calabrese LH, Calabrese C, Lenfant T, Kirchner E, Strand V. Infections in the Era of Targeted Therapies: Mapping the Road Ahead. Front Med (Lausanne) 2020;7:336. [PMID: 32974356 DOI: 10.3389/fmed.2020.00336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kordzadeh-Kermani E, Khalili H, Karimzadeh I, Salehi M. Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators. Infect Drug Resist 2020;13:513-32. [PMID: 32110062 DOI: 10.2147/IDR.S233137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:879-913. [PMID: 33730753 DOI: 10.1093/ecco-jcc/jjab052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Portais A, Le Marechal M, Nemoz B, Dartevel A, Rigault G, Pavese P, Pierre I, Terzi N. Measles-associated pneumonia in an immunocompromised patient: Persistent shortcomings in vaccination guidelines. Infect Dis Now 2021;51:316-8. [PMID: 33934814 DOI: 10.1016/j.idnow.2020.11.004] [Reference Citation Analysis]
28 Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, Lee MS, Hong SJ, Choi BY, Lee SS, Back HJ; Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune Inflammatory Rheumatic Diseases. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology. J Korean Med Sci 2021;36:e95. [PMID: 33783147 DOI: 10.3346/jkms.2021.36.e95] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
29 Szwejkowska M, Kuchar E. Vaccinations in rheumatic diseases. Reumatologia 2020;58:61-2. [PMID: 32476676 DOI: 10.5114/reum.2020.95358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Chan W, Salazar E, Lim TG, Ong WC, Shim HH. Vaccinations and inflammatory bowel disease - a systematic review. Dig Liver Dis 2021;53:1079-88. [PMID: 33994128 DOI: 10.1016/j.dld.2021.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Björk A, Mofors J, Wahren-Herlenius M. Environmental factors in the pathogenesis of primary Sjögren's syndrome. J Intern Med 2020;287:475-92. [PMID: 32107824 DOI: 10.1111/joim.13032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
32 Richi P, Yuste J, Navío T, González-Hombrado L, Salido M, Thuissard-Vasallo I, Jiménez-Díaz A, Llorente J, Cebrián L, Lojo L, Steiner M, Cobo T, Martín MD, García-Castro M, Castro P, Muñoz-Fernández S. Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases. Vaccines (Basel) 2021;9:203. [PMID: 33671007 DOI: 10.3390/vaccines9030203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Rotondo C, Cantatore FP, Fornaro M, Colia R, Busto G, Rella V, Sciacca S, Lops L, Cici D, Maruotti N, D'Onofrio F, Iannone F, Corrado A. Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study. Vaccines (Basel) 2021;9:730. [PMID: 34358147 DOI: 10.3390/vaccines9070730] [Reference Citation Analysis]
34 Keller M, Pittet LF, Zimmermann P. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review. Eur J Pediatr 2021. [PMID: 34936010 DOI: 10.1007/s00431-021-04283-w] [Reference Citation Analysis]
35 Mehta P, Sanchez E, Moraitis E, Longley N, Lendrem DW, Giles IP, Chambers RC, Ciurtin C, Isaacs JD. Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma. Lancet Rheumatol 2021;3:e9-e10. [PMID: 33521669 DOI: 10.1016/S2665-9913(20)30392-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Mason A, Anver H, Lwin M, Holroyd C, Faust SN, Edwards CJ. Lupus, vaccinations and COVID-19: What we know now. Lupus 2021;:9612033211024355. [PMID: 34134555 DOI: 10.1177/09612033211024355] [Reference Citation Analysis]
37 Rasmussen SL, Strandbygaard LL, Fuursted K, Kragholm KH, Leutscher P, Rasmussen C. Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination. Scand J Rheumatol 2022;:1-7. [PMID: 35049423 DOI: 10.1080/03009742.2021.2008602] [Reference Citation Analysis]
38 Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, Caporali R. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Res Ther 2022;24:21. [PMID: 35016701 DOI: 10.1186/s13075-021-02674-w] [Reference Citation Analysis]
39 Harris JG. Improving Pneumococcal Vaccination Rates in Rheumatology Clinics. J Rheumatol 2021;48:1361-3. [PMID: 33934069 DOI: 10.3899/jrheum.210058] [Reference Citation Analysis]
40 Dos Reis BS, Staub FC, Koishi A, Zanluca C, Dos Santos CND, Skare TL, Kahlow BS. Seroconversion of rheumatoid arthritis patients after yellow fever vaccination. Clin Rheumatol 2021. [PMID: 34674083 DOI: 10.1007/s10067-021-05962-7] [Reference Citation Analysis]
41 Olivieri B, Betterle C, Zanoni G. Vaccinations and Autoimmune Diseases. Vaccines (Basel) 2021;9:815. [PMID: 34451940 DOI: 10.3390/vaccines9080815] [Reference Citation Analysis]
42 Campochiaro C, Trignani G, Tomelleri A, Cascinu S, Dagna L; COVID-19 Vaccine Study Group. Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey. Ann Rheum Dis 2021:annrheumdis-2020-219811. [PMID: 33509795 DOI: 10.1136/annrheumdis-2020-219811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
43 Richi P, Steiner M, Muñoz-Fernández S. Reply. Med Clin (Barc) 2021;156:254-5. [PMID: 32359964 DOI: 10.1016/j.medcli.2020.03.001] [Reference Citation Analysis]
44 Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, Mikuls TR. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3. Arthritis Rheumatol 2021. [PMID: 34346564 DOI: 10.1002/art.41928] [Reference Citation Analysis]
45 Krasselt M, Baerwald C, Petros S, Seifert O. Sepsis Mortality Is high in Patients With Connective Tissue Diseases Admitted to the Intensive Care Unit (ICU). J Intensive Care Med 2021;:885066621996257. [PMID: 33631998 DOI: 10.1177/0885066621996257] [Reference Citation Analysis]
46 Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin 2021:S1699-258X(21)00124-8. [PMID: 34176767 DOI: 10.1016/j.reuma.2021.04.006] [Reference Citation Analysis]
47 Smolen JS. Greetings from the editor 2020. Ann Rheum Dis 2019;79:1-2. [DOI: 10.1136/annrheumdis-2019-216758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
48 Greek Rheumatology Society and Professional Association of Rheumatologists (ERE-EPERE). Vaccination Against SARS-CoV-2 in Immunosuppressed Patients with Rheumatic Diseases: Position Statement of the Greek Rheumatology Society. Mediterr J Rheumatol 2020;31:430-2. [PMID: 33521579 DOI: 10.31138/mjr.31.4.430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Taylor PC, Atzeni F, Balsa A, Gossec L, Müller-Ladner U, Pope J. The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review. J Clin Med 2021;10:509. [PMID: 33535498 DOI: 10.3390/jcm10030509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Calabrese C. Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy. Med Clin North Am 2021;105:213-25. [PMID: 33589098 DOI: 10.1016/j.mcna.2020.09.008] [Reference Citation Analysis]
51 Constantinou CA, Ziogas DC, Venetsanopoulou A, Gamaletsou MN, Koutsogeorgopoulou L, Barbouni A, Tzioufas AG, Sipsas NV. A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness. Vaccine 2021;39:1593-7. [PMID: 33610375 DOI: 10.1016/j.vaccine.2021.02.009] [Reference Citation Analysis]
52 Stingeni L, Bianchi L, Peris K, Fabbrocini G, Micali G, Calzavara-Pinton P, Tramontana M, Hansel K; Board Members of SIDeMaST. SARS-CoV-2 vaccines and biological treatments: dermatological perspectives. Ital J Dermatol Venerol 2021;156:118-20. [PMID: 33960748 DOI: 10.23736/S2784-8671.21.07055-9] [Reference Citation Analysis]
53 Patel D, Maczuga S, Helm MF, Foulke GT. A retrospective cohort study confirms that prophylactic vaccination is underused in patients on tumor necrosis factor inhibitors. J Am Acad Dermatol 2021;84:1150-2. [PMID: 32679277 DOI: 10.1016/j.jaad.2020.07.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Leibowitz JA, Woods AT, Kesselman MM, Mayi BS. Uveitis as a Predictor of Predisposition to Autoimmunity. Cureus 2020;12:e7451. [PMID: 32351830 DOI: 10.7759/cureus.7451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Buschulte K, Hoffmann-Vold AM, Dobrota RD, Höger P, Krause A, Kreuter M. [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]. Z Rheumatol 2021;80:743-54. [PMID: 34505934 DOI: 10.1007/s00393-021-01067-3] [Reference Citation Analysis]
56 Santosa A, Xu C, Arkachaisri T, Kong KO, Lateef A, Lee TH, Leong KH, Low AHL, Sriranganathan MK, Tan TC, Teng GG, Thong BY, Fong W, Lahiri M. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists. Int J Rheum Dis 2021;24:746-57. [PMID: 33973379 DOI: 10.1111/1756-185X.14107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
57 Chavatza K, Kostopoulou M, Nikolopoulos D, Gioti O, Togia K, Andreoli L, Aringer M, Boletis J, Doria A, Houssiau FA, Jayne D, Mosca M, Svenungsson E, Tincani A, Bertsias G, Fanouriakis A, Boumpas DT. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients. Ann Rheum Dis 2021;80:1175-82. [PMID: 34162597 DOI: 10.1136/annrheumdis-2021-220438] [Reference Citation Analysis]
58 Geisen UM, Berner DK, Tran F, Sümbül M, Vullriede L, Ciripoi M, Reid HM, Schaffarzyk A, Longardt AC, Franzenburg J, Hoff P, Schirmer JH, Zeuner R, Friedrichs A, Steinbach A, Knies C, Markewitz RD, Morrison PJ, Gerdes S, Schreiber S, Hoyer BF. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis 2021;80:1306-11. [PMID: 33762264 DOI: 10.1136/annrheumdis-2021-220272] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 56.0] [Reference Citation Analysis]
59 Tedeschi SK, Ellrodt J, Stratton J, Santacroce L, Chandler PD, Gravallese EM, Solomon DH. Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease. ACR Open Rheumatol 2021. [PMID: 34613668 DOI: 10.1002/acr2.11351] [Reference Citation Analysis]
60 Sugihara T. Treatment strategies for elderly-onset rheumatoid arthritis in the new era. Mod Rheumatol 2021:roab087. [PMID: 34791359 DOI: 10.1093/mr/roab087] [Reference Citation Analysis]
61 Stephan B, Tittelbach J, Bühler S. Considerations for patients with psoriasis travelling under immunosuppression. J Dtsch Dermatol Ges 2021;19:197-207. [PMID: 33491922 DOI: 10.1111/ddg.14377] [Reference Citation Analysis]
62 Živković SA, Gruener G, Narayanaswami P; AANEM Quality and Patient Safety Committee. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders. Muscle Nerve 2021;63:294-303. [PMID: 33471383 DOI: 10.1002/mus.27179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
63 Firinu D, Perra A, Campagna M, Littera R, Fenu G, Meloni F, Cipri S, Sedda F, Conti M, Miglianti M, Costanzo G, Secci M, Usai G, Carta MG, Cappai R, Orrù G, Del Giacco S, Coghe F, Chessa L. Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination. Clin Exp Med 2021. [PMID: 34741188 DOI: 10.1007/s10238-021-00771-3] [Reference Citation Analysis]
64 Waldron JL, Schworer SA, Kwan M. Hypersensitivity and Immune-related Adverse Events in Biologic Therapy. Clin Rev Allergy Immunol 2021. [PMID: 34319562 DOI: 10.1007/s12016-021-08879-w] [Reference Citation Analysis]
65 Privor-Dumm L. Determinants of policy and uptake of national vaccine programs for pregnant women: results of mixed method study from Spain, Italy, and India. Hum Vaccin Immunother 2021;17:1474-82. [PMID: 33215935 DOI: 10.1080/21645515.2020.1831858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Nalli C, Galli J, Lini D, Merlini A, Piantoni S, Lazzaroni MG, Bitsadze V, Khizroeva J, Zatti S, Andreoli L, Fazzi E, Franceschini F, Makatsariya A, Shoenfeld Y, Tincani A. The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. Front Pharmacol 2021;12:626258. [PMID: 33815108 DOI: 10.3389/fphar.2021.626258] [Reference Citation Analysis]
67 Valerio V, Bazan MC, Wang M, Mazer BD, Pineau CA, Hazel EM, Bernatsky S, Ward BJ, Colmegna I. A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritis. Clin Rheumatol 2021;40:575-9. [PMID: 33030631 DOI: 10.1007/s10067-020-05435-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Rezende RPV, Cardoso-Marques NT, Rodrigues LAS, Almeida JPCL, Pillegi GS, Teixeira LM, Klumb EM, Neves FPG. Carriage prevalence, serotype distribution, and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus. Lupus 2021;:9612033211030549. [PMID: 34225521 DOI: 10.1177/09612033211030549] [Reference Citation Analysis]
69 Cherian S, Paul A, Ahmed S, Alias B, Manoj M, Santhosh AK, Varghese DR, Krishnan N, Shenoy P. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int 2021;41:1441-5. [PMID: 34142203 DOI: 10.1007/s00296-021-04917-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Canzoni M, Marignani M, Sorgi ML, Begini P, Biondo MI, Caporuscio S, Colonna V, Casa FD, Conigliaro P, Marrese C, Celletti E, Modesto I, Peragallo MS, Laganà B, Picchianti-Diamanti A, Rosa RD, Ferlito C, Salemi S, D'Amelio R, Stroffolini T. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy. Microorganisms 2020;8:E1792. [PMID: 33207663 DOI: 10.3390/microorganisms8111792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
71 Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Ann Rheum Dis 2020:annrheumdis-2020-218244. [PMID: 32586921 DOI: 10.1136/annrheumdis-2020-218244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
72 Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol 2021;12:708848. [PMID: 34659200 DOI: 10.3389/fimmu.2021.708848] [Reference Citation Analysis]
73 Lenfant T, Jin Y, Kirchner E, Hajj-Ali RA, Calabrese LH, Calabrese C. Safety of Recombinant Zoster Vaccine: a Retrospective Study of 622 Rheumatology Patients. Rheumatology (Oxford) 2021:keab139. [PMID: 33560302 DOI: 10.1093/rheumatology/keab139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Qian J, Lassere MN, Heywood AE, Liu B. Use of disease-modifying antirheumatic drugs and the subsequent risk of herpes zoster in older adults. Rheumatology (Oxford) 2021;60:5042-51. [PMID: 34508560 DOI: 10.1093/rheumatology/keab538] [Reference Citation Analysis]
75 Stephan B, Tittelbach J, Bühler S. Reisevorbereitungen für Patienten mit Psoriasis unter Immunsuppression. J Dtsch Dermatol Ges 2021;19:197-208. [PMID: 33586903 DOI: 10.1111/ddg.14377_g] [Reference Citation Analysis]
76 Potera J, Kambhatla S, Gauto-Mariotti E, Manadan A. Incidence, mortality, and national costs of hospital admissions for potentially preventable infections in patients with rheumatoid arthritis. Clin Rheumatol 2021. [PMID: 34254210 DOI: 10.1007/s10067-021-05836-y] [Reference Citation Analysis]
77 López-Medina C, Molto A. Comorbidity management in spondyloarthritis. RMD Open 2020;6:e001135. [PMID: 32892168 DOI: 10.1136/rmdopen-2019-001135] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Scott-Charlton A, Reynolds G. A case of systemic lupus erythematosus associated auto-splenectomy presenting as invasive pneumococcal sepsis. Mod Rheumatol Case Rep 2020;4:233-6. [PMID: 33087009 DOI: 10.1080/24725625.2020.1751407] [Reference Citation Analysis]
79 Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, Marriott JJ, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study. CMAJ Open 2021;9:E510-21. [PMID: 33990365 DOI: 10.9778/cmajo.20200105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Ladouceur A, Tessier-Cloutier B, Clarke AE, Ramsey-Goldman R, Gordon C, Hansen JE, Bernatsky S. Cancer and Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2020;46:533-50. [PMID: 32631602 DOI: 10.1016/j.rdc.2020.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, Mikuls TR. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2. Arthritis Rheumatol 2021;73:e30-45. [PMID: 34128356 DOI: 10.1002/art.41877] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
82 Ostrov BE, Amsterdam D. Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory Diseases. Immunol Invest 2021;50:833-56. [PMID: 33941025 DOI: 10.1080/08820139.2021.1900863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Ann Rheum Dis 2021;80:71-87. [PMID: 33158881 DOI: 10.1136/annrheumdis-2020-218398] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
84 Xiao F, Han M, Zhu X, Tang Y, Huang E, Zou H, Jiang Q, Lu L. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases. Mod Rheumatol 2021;31:927-32. [PMID: 33427554 DOI: 10.1080/14397595.2020.1868673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Nived P, Pettersson Å, Jönsson G, Bengtsson AA, Settergren B, Skattum L, Johansson Å, Kapetanovic MC. Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients. Sci Rep 2021;11:9199. [PMID: 33911135 DOI: 10.1038/s41598-021-88491-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Valerio V, Hudson M, Wang M, Bernatsky S, Hazel EM, Ward B, Colmegna I. Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients. ACR Open Rheumatol 2022. [PMID: 35049149 DOI: 10.1002/acr2.11408] [Reference Citation Analysis]
87 Kneitz C, Müller-Ladner U. [Most important vaccinations in patients with rheumatological diseases and why]. Z Rheumatol 2020;79:855-64. [PMID: 32955610 DOI: 10.1007/s00393-020-00875-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Claudino Formiga FF, Silva CA, Pedrosa TDN, Aikawa NE, Pasoto SG, Garcia CC, Capão ASV, Martins VAO, Proença ACT, Fuller R, Yuki EFN, Vendramini MBG, Rosário DCD, Brandão LMKR, Sartori AMC, Antonangelo L, Bonfá E, Borba EF. Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicity. Lupus 2021;30:1915-22. [PMID: 34459317 DOI: 10.1177/09612033211040371] [Reference Citation Analysis]
89 Winchester N, Calabrese C, Calabrese LH. The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding? Pathog Immun 2021;6:31-54. [PMID: 33969248 DOI: 10.20411/pai.v6i1.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Cairoli E, Espinosa G. [Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios]. Med Clin (Barc) 2021;157:247-52. [PMID: 34140165 DOI: 10.1016/j.medcli.2021.05.008] [Reference Citation Analysis]
91 Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J. Immunizations in immunocompromised patients: a guide for dermatologists. J Dtsch Dermatol Ges 2020;18:699-723. [PMID: 32713146 DOI: 10.1111/ddg.14156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Rosamilia F, Noberasco G, Olobardi D, Orsi A, Icardi G, Lantieri F, Murdaca G. Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review. Vaccines (Basel) 2021;9:1330. [PMID: 34835261 DOI: 10.3390/vaccines9111330] [Reference Citation Analysis]
93 Evangelatos G, Fragoulis GE, Iliopoulos A. A Varicella Case After Herpes-Zoster Vaccination in a Patient Treated With a Tumor Necrosis Factor Inhibitor. J Clin Rheumatol 2021;27:e295-6. [PMID: 32501941 DOI: 10.1097/RHU.0000000000001420] [Reference Citation Analysis]
94 Kostik MM, Lubimova NA, Fridman IV, Goleva OV, Kharit SM. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatr Rheumatol Online J 2021;19:108. [PMID: 34225748 DOI: 10.1186/s12969-021-00594-2] [Reference Citation Analysis]
95 Friedman MA, Curtis JR, Winthrop KL. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis 2021;80:1255-65. [PMID: 34493491 DOI: 10.1136/annrheumdis-2021-221244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Nived P, Jönsson G, Settergren B, Einarsson J, Olofsson T, Jørgensen CS, Skattum L, Kapetanovic MC. Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients. Arthritis Res Ther 2020;22:36. [PMID: 32087733 DOI: 10.1186/s13075-020-2124-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Krasselt M, Baerwald C, Petros S, Seifert O. Outcome of Patients With Necrotizing Vasculitis Admitted to the Intensive Care Unit (ICU) for Sepsis: Results of a Single-Centre Retrospective Analysis. J Intensive Care Med 2021;36:1410-6. [PMID: 32873111 DOI: 10.1177/0885066620953768] [Reference Citation Analysis]
98 Meißner Y, Strangfeld A. [Latest findings from the RABBIT register]. Z Rheumatol 2021. [PMID: 34940891 DOI: 10.1007/s00393-021-01139-4] [Reference Citation Analysis]
99 Krasselt M, Baerwald C, Liebert UG, Seifert O. Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls. Vaccines (Basel) 2021;9:325. [PMID: 33915820 DOI: 10.3390/vaccines9040325] [Reference Citation Analysis]
100 Otero-Romero S, Ascherio A, Lebrun-Frénay C. Vaccinations in multiple sclerosis patients receiving disease-modifying drugs. Curr Opin Neurol 2021;34:322-8. [PMID: 33709979 DOI: 10.1097/WCO.0000000000000929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
101 Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford) 2020;59:v29-38. [PMID: 33280012 DOI: 10.1093/rheumatology/keaa382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
102 Manansala M, Chopra A, Baughman RP, Novak R, Lower EE, Culver DA, Korsten P, Drake WP, Judson MA, Sweiss N. COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities. Front Med (Lausanne) 2021;8:672028. [PMID: 33996868 DOI: 10.3389/fmed.2021.672028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Peet CJ, Papadopoulou C, Sombrito BRM, Wood MR, Lachmann HJ. COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics. Rheumatol Adv Pract 2021;5:rkab043. [PMID: 34466775 DOI: 10.1093/rap/rkab043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Hazlewood GS, Pardo JP, Barnabe C, Schieir O, Barber CEH, Bernatsky S, Colmegna I, Hitchon C, Loeb M, Mertz D, Proulx L, Richards DP, Scuccimarri R, Tugwell P, Schünemann HJ, Mirza RD, Zhou AL, Nikolic RPA, Thomas M, Chase H, Ejaredar M, Nieuwlaat R. Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases. J Rheumatol 2021;48:1330-9. [PMID: 33993119 DOI: 10.3899/jrheum.210288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Prata AR, Luís M, Assunção H, da Silva JAP, Inês LS. Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study. Clin Rheumatol 2021. [PMID: 34782940 DOI: 10.1007/s10067-021-05988-x] [Reference Citation Analysis]
106 Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford) 2021;60:60-72. [PMID: 33099651 DOI: 10.1093/rheumatology/keaa478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Ammitzbøll C, Bartels LE, Bøgh Andersen J, Risbøl Vils S, Elbaek Mistegård C, Dahl Johannsen A, From Hermansen ML, Kragh Thomsen M, Erikstrup C, Hauge EM, Troldborg A. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. ACR Open Rheumatol 2021. [PMID: 34273260 DOI: 10.1002/acr2.11299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Velikova T, Georgiev T. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021;41:509-518. [PMID: 33515320 DOI: 10.1007/s00296-021-04792-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 22.0] [Reference Citation Analysis]
109 Venerito V, Stefanizzi P, Fornaro M, Cacciapaglia F, Tafuri S, Perniola S, Iannone F, Lopalco G. Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors. RMD Open 2022;8:e001847. [PMID: 34987092 DOI: 10.1136/rmdopen-2021-001847] [Reference Citation Analysis]
110 Kearsley-Fleet L, Klotsche J, van Straalen JW, Costello W, D'Angelo G, Giancane G, Horneff G, Klein A, Láday M, Lunt M, de Roock S, Ruperto N, Schoemaker C, Vijatov-Djuric G, Vojinovic J, Vougiouka O, Wulffraat NM, Hyrich KL, Minden K, Swart JF; UK JIA Biologics Registers Investigators Group; Paediatric Rheumatology International Trials Organisation (PRINTO). Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries. Rheumatology (Oxford) 2021:keab641. [PMID: 34613385 DOI: 10.1093/rheumatology/keab641] [Reference Citation Analysis]
111 Adami G, Saag KG, Chapurlat RD, Guañabens N, Haugeberg G, Lems WF, Matijevic R, Peel N, Poddubnyy D, Geusens P. Balancing benefits and risks in the era of biologics. Ther Adv Musculoskelet Dis 2019;11:1759720X19883973. [PMID: 31695755 DOI: 10.1177/1759720X19883973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
112 D'Amelio R, Asero R, Cassatella MA, Laganà B, Lunardi C, Migliorini P, Nisini R, Parronchi P, Quinti I, Racanelli V, Senna G, Vacca A, Maggi E. Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies. Biomedicines 2021;9:1163. [PMID: 34572349 DOI: 10.3390/biomedicines9091163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Krasselt M, Baerwald C, Petros S, Seifert O. Mortality of Sepsis in Patients With Rheumatoid Arthritis: A Single-Center Retrospective Analysis and Comparison With a Control Group. J Intensive Care Med 2021;36:766-74. [PMID: 32249644 DOI: 10.1177/0885066620917588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Okusaki T, Fukuhara K. Exacerbation of connective tissue disease-associated interstitial lung disease due to influenza vaccination. Respir Med Case Rep 2021;33:101463. [PMID: 34401299 DOI: 10.1016/j.rmcr.2021.101463] [Reference Citation Analysis]
115 Wee LE, Conceicao EP, Tan JY, Thumboo J, Venkatachalam I. Correspondence on 'Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study'. Ann Rheum Dis 2021:annrheumdis-2021-220462. [PMID: 33837047 DOI: 10.1136/annrheumdis-2021-220462] [Reference Citation Analysis]
116 Di Bartolomeo S, Alunno A, Carubbi F. Respiratory Manifestations in Systemic Lupus Erythematosus. Pharmaceuticals (Basel) 2021;14:276. [PMID: 33803847 DOI: 10.3390/ph14030276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
117 Doneddu PE, Spina E, Briani C, Fabrizi GM, Manganelli F, Nobile-Orazio E; Italian Peripheral Nervous System Association (ASNP). Acute and chronic inflammatory neuropathies and COVID-19 vaccines: Practical recommendations from the task force of the Italian Peripheral Nervous System Association (ASNP). J Peripher Nerv Syst 2021;26:148-54. [PMID: 33620123 DOI: 10.1111/jns.12435] [Reference Citation Analysis]
118 Galleguillos L, Alonso R. Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis. Mult Scler Relat Disord 2021;54:103142. [PMID: 34298479 DOI: 10.1016/j.msard.2021.103142] [Reference Citation Analysis]
119 Schulze-Koops H, Specker C, Skapenko A. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open 2021;7:e001553. [PMID: 33627439 DOI: 10.1136/rmdopen-2020-001553] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
120 Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol 2020;16:527-38. [PMID: 32478627 DOI: 10.1080/1744666X.2020.1763793] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
121 Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E. Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases. PLoS Negl Trop Dis 2021;15:e0010002. [PMID: 34843469 DOI: 10.1371/journal.pntd.0010002] [Reference Citation Analysis]
122 Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, de Thurah A, Mueller-Ladner U, Paran D, Schreiber K, Warnatz K, Wulffraat NM, Elkayam O. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open 2021;7:e001594. [PMID: 33627440 DOI: 10.1136/rmdopen-2021-001594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
123 Grein IHR, Pinto NBF, Groot N, Martins CB, Lobo A, Aikawa NE, Barbosa C, Terreri MT, da Fraga ACM, de Oliveira SKF, Sztajnbok F, Paim Marques LB, Islabão AG, Appenzeller S, Bica B, de Oliveira Sato J, Magalhães CS, Ferriani V, Pasmans H, Schepp R, van der Klis F, de Roock S, Wulffraat N, Pileggi GS. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study. Pediatr Rheumatol Online J 2020;18:87. [PMID: 33176806 DOI: 10.1186/s12969-020-00479-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Costello RE, Humphreys JH, Winthrop KL, Dixon WG. Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Ann Rheum Dis 2020;79:1665-6. [PMID: 32591355 DOI: 10.1136/annrheumdis-2020-217255] [Reference Citation Analysis]
125 Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol 2021;17:561-71. [PMID: 33787418 DOI: 10.1080/1744666X.2021.1908887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Adas MA, Alveyn E, Cook E, Dey M, Galloway JB, Bechman K. The infection risks of JAK inhibition. Expert Rev Clin Immunol 2021;:1-9. [PMID: 34860621 DOI: 10.1080/1744666X.2022.2014323] [Reference Citation Analysis]
127 Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38:337-342. [PMID: 32202240 DOI: 10.1016/j.autrev.2020.102574] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
128 Redeker I, Albrecht K, Kekow J, Burmester GR, Braun J, Schäfer M, Zink A, Strangfeld A. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Ann Rheum Dis 2021:annrheumdis-2021-220651. [PMID: 34321218 DOI: 10.1136/annrheumdis-2021-220651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Pfaar O, Klimek L, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen N, Becker S, Worm M. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA). Allergol Select 2021;5:140-7. [PMID: 33842829 DOI: 10.5414/ALX02241E] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 Vecchié A, Del Buono MG, Chiabrando GJ, Dentali F, Abbate A, Bonaventura A. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease. Curr Cardiol Rep 2021;23:157. [PMID: 34599390 DOI: 10.1007/s11886-021-01589-x] [Reference Citation Analysis]
131 Boucher VG, Pelaez S, Gemme C, Labbe S, Lavoie KL. Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review. Clin Rheumatol 2021;40:477-89. [PMID: 32621081 DOI: 10.1007/s10067-020-05059-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
132 Calvet X, Carpio D, Rodríguez-Lago I, García-Vicuña R, Barreiro-de-Acosta M, Juanola X, Aguas M, Castillo C, Gratacós J. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterol Hepatol 2021:S0210-5705(21)00056-X. [PMID: 33640469 DOI: 10.1016/j.gastrohep.2021.01.007] [Reference Citation Analysis]
133 Westhoff TH, Seibert FS, Anft M, Blazquez-Navarro A, Skrzypczyk S, Doevelaar A, Hölzer B, Paniskaki K, Dolff S, Wilde B, Witzke O, Braun J, Stervbo U, Babel N. Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'. Ann Rheum Dis 2021;80:e162. [PMID: 34272253 DOI: 10.1136/annrheumdis-2021-220756] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
134 Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, Kim G, Kim HS, Lee MS, Lee J, Hur JA, Chin BS, Eom JS, Baek HJ; Korean College of Rheumatology working group. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med 2020;35:1317-32. [PMID: 32972125 DOI: 10.3904/kjim.2020.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
135 Cantarelli C, Guglielmo C, Hartzell S, Salem FE, Andrighetto S, Gazivoda VP, Fiaccadori E, La Manna G, Zaza G, Leventhal J, Tassiulas I, Cravedi P. Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus. Front Immunol 2019;10:2695. [PMID: 31824490 DOI: 10.3389/fimmu.2019.02695] [Reference Citation Analysis]
136 Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 2021;80:14-25. [PMID: 33051219 DOI: 10.1136/annrheumdis-2020-218272] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
137 Pinte L, Negoi F, Ionescu GD, Caraiola S, Balaban DV, Badea C, Mazilu D, Dumitrescu B, Mateescu B, Ionescu R, Parvu MI, Baicus C. COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases. J Pers Med 2021;11:1283. [PMID: 34945754 DOI: 10.3390/jpm11121283] [Reference Citation Analysis]
138 Oku K, Hamijoyo L, Kasitanon N, Li MT, Navarra S, Morand E, Tanaka Y, Mok CC. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. Int J Rheum Dis 2021;24:880-95. [PMID: 33999518 DOI: 10.1111/1756-185X.14125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
139 Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Richez C, Pham T. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105210. [PMID: 34074455 DOI: 10.1016/j.jbspin.2021.105210] [Reference Citation Analysis]
140 Atzeni F, Nucera V, Gerratana E, Cirillo M, Marino F, Miceli G, Sangari D, Boccassini L, Masala IF. Concerns about the safety of anti-TNF agents when treating rheumatic diseases. Expert Opinion on Drug Safety 2020;19:695-705. [DOI: 10.1080/14740338.2020.1763299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
141 Kvien TK, Balsa A, Betteridge N, Buch MH, Durez P, Favalli EG, Favier G, Gabay C, Geenen R, Gouni-Berthold I, van den Hoogen F, Kent A, Klareskog L, Ostergaard M, Pavelka K, Polido Pereira J, Semb AG, Sköld M, Dougados M. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD Open 2020;6:e001211. [PMID: 32683326 DOI: 10.1136/rmdopen-2020-001211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
142 Gasparyan AY, Misra DP, Yessirkepov M, Zimba O. Perspectives of Immune Therapy in Coronavirus Disease 2019. J Korean Med Sci 2020;35:e176. [PMID: 32383371 DOI: 10.3346/jkms.2020.35.e176] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
143 Pileggi GS, Ferreira GA, Reis APMG, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa ED, Borba EF, Brito DCSE, Duarte ÂLBP, Santo RCE, Fernandes PR, Guimarães MP, Gomes KWP, Kakehasi AM, Klumb EM, Lanna CCD, Marques CDL, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Junior LFR, Sampaio CSJC, Sampaio VS, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Pinheiro MM. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil. Adv Rheumatol 2021;61:60. [PMID: 34620246 DOI: 10.1186/s42358-021-00217-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Ceccarelli F, Olivieri G, Natalucci F, Alessandri C, Conti F. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case. Lupus 2021;:9612033211027940. [PMID: 34192958 DOI: 10.1177/09612033211027940] [Reference Citation Analysis]
145 Bednarek A, Klepacz R. Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis. J Clin Med 2020;9:E3736. [PMID: 33233818 DOI: 10.3390/jcm9113736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Yoshihara R, Komai T, Shoda H, Fujio K. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases. Int J Rheum Dis 2020;23:1534-40. [PMID: 33051990 DOI: 10.1111/1756-185X.13990] [Reference Citation Analysis]
147 Colmegna I, Valerio V, Boucher VG, Lacoste G, Labbe S, Lavoie KL, Hazel E, Ward B, Hudson M, Pelaez S. Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study. Rheumatology (Oxford) 2021:keab471. [PMID: 34086876 DOI: 10.1093/rheumatology/keab471] [Reference Citation Analysis]
148 Thomas K, Lazarini A, Kaltsonoudis E, Voulgari PV, Drosos AA, Repa A, Sali AMI, Sidiropoulos P, Tsatsani P, Gazi S, Evangelia A, Boki KA, Katsimbri P, Boumpas D, Fragkiadaki K, Tektonidou MG, Sfikakis PP, Karagianni K, Sakkas LI, Grika EP, Vlachoyiannopoulos PG, Evangelatos G, Iliopoulos A, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Areti M, Georganas C, Vounotrypidis P, Georgiopoulos G, Kitas GD, Vassilopoulos D. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis. Rheumatology (Oxford) 2021;60:2223-30. [PMID: 33295627 DOI: 10.1093/rheumatology/keaa557] [Reference Citation Analysis]
149 Sunzini F, McInnes I, Siebert S. JAK inhibitors and infections risk: focus on herpes zoster. Ther Adv Musculoskelet Dis 2020;12:1759720X20936059. [PMID: 32655703 DOI: 10.1177/1759720X20936059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
150 Campanati A, Diotallevi F, Martina E, Paolinelli M, Radi G, Offidani A. Safety update of etanercept treatment for moderate to severe plaque psoriasis. Expert Opin Drug Saf 2020;19:439-48. [PMID: 32178543 DOI: 10.1080/14740338.2020.1740204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
151 Richi P, Alonso O, Martín MD, González-Hombrado L, Navío T, Salido M, Llorente J, Andreu-Vázquez C, García-Fernández C, Jiménez-Diaz A, Lojo L, Cebrián L, Thuissard-Vasallo I, Martínez de Aramayona MJ, Cobo T, García-Castro M, Castro P, Fernández-Castro M, Illera Ó, Steiner M, Muñoz-Fernández S. Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study. Clin Rheumatol 2020;39:2751-6. [PMID: 32248433 DOI: 10.1007/s10067-020-05042-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
152 Fatani MIA, Hamadah IRA, Alajlan MA, Binamer Y, Alharbi AHS, Alruwaili AFS, Aldayel MAA, Alenzi KAO, Mubarki SM, Khardaly AM, Alomari BAA, Almudaiheem HY, Al-Jedai A, Eshmawi MTY. Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020). J Dermatolog Treat 2021;:1-15. [PMID: 34284704 DOI: 10.1080/09546634.2021.1950601] [Reference Citation Analysis]
153 Morel J, Letaief H, Guilpain P, Mariette X, Combe B, Lukas C. Low Influenza, Pneumococcal and Diphtheria-Tetanus-Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren's Syndrome: A Cross-Sectional Study. Vaccines (Basel) 2019;8:E3. [PMID: 31877764 DOI: 10.3390/vaccines8010003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
154 Bechman K, Dey M, Yates M, Bukhari M, Winthrop K, Galloway JB. The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know. J Rheumatol 2021;48:1201-4. [PMID: 34074678 DOI: 10.3899/jrheum.210106] [Reference Citation Analysis]
155 Hasseli R, Pfeil A, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C; COVID-19 Task Force of the German Society for Rheumatology (DGRh). A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany. Rheumatol Int 2021;41:1949-56. [PMID: 34498112 DOI: 10.1007/s00296-021-04986-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Toplak N, Uziel Y. Vaccination for Children on Biologics. Curr Rheumatol Rep 2020;22:26. [PMID: 32436130 DOI: 10.1007/s11926-020-00905-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
157 Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Sadun RE, Turner AS, Williams EA, Mikuls TR. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1. Arthritis Rheumatol 2021;73:1093-107. [PMID: 33728796 DOI: 10.1002/art.41734] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 35.0] [Reference Citation Analysis]
158 Lee KH, Choi S, Kwon JS, Kim SH, Park SY. Varicella zoster virus (VZV)-specific immunity and subclinical VZV reactivation in patients with autoimmune diseases. Korean J Intern Med 2021;36:992-1000. [PMID: 34126665 DOI: 10.3904/kjim.2020.672] [Reference Citation Analysis]
159 Murdaca G, Noberasco G, Olobardi D, Lunardi C, Maule M, Delfino L, Triggiani M, Cardamone C, Benfaremo D, Moroncini G, Vacca A, Susca N, Gangemi S, Quattrocchi P, Sticchi L, Icardi G, Orsi A. Current Take on Systemic Sclerosis Patients' Vaccination Recommendations. Vaccines (Basel) 2021;9:1426. [PMID: 34960174 DOI: 10.3390/vaccines9121426] [Reference Citation Analysis]
160 Tavares ACFMG, de Melo AKG, Cruz VA, de Souza VA, de Carvalho JS, Machado KLLL, de Azevedo Valadares LD, Dos Reis Neto ET, de Rezende RPV, de Resende Guimarães MFB, Ferreira GA, de Sousa Braz A, de Abreu Vieira RMR, de Medeiros Pinheiro M, Ribeiro SLE, Bica BEGR, Baptista KL, da Costa IP, Marques CDL, Lopes MLL, Martinez JE, Giorgi RDN, da Mota LMH, da Rocha Loures MAA, Dos Santos Paiva E, Monticielo OA, Xavier RM, Kakehasi AM, Pileggi GCS. Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force. Adv Rheumatol 2022;62:3. [PMID: 35039077 DOI: 10.1186/s42358-022-00234-7] [Reference Citation Analysis]
161 Tse HN, Borrow R, Arkwright PD. Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy. Expert Rev Vaccines 2020;19:1115-27. [PMID: 33507119 DOI: 10.1080/14760584.2021.1875825] [Reference Citation Analysis]
162 Roy B, Litchman T, Torabi T, Nowak RJ. Influenza vaccination in autoimmune neuromuscular diseases: A survey of current practices and perceptions. Muscle Nerve 2021;63:918-23. [PMID: 33711167 DOI: 10.1002/mus.27224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Druyan A, Lidar M, Brodavka M, Levy I, Barzilai A, Pavlotsky F. The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons. Dermatol Ther 2021;34:e14627. [PMID: 33277764 DOI: 10.1111/dth.14627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Liozon E, Parreau S, Filloux M, Dumonteil S, Gondran G, Bezanahary H, Ly KH, Fauchais AL. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmun Rev 2021;20:102732. [PMID: 33326851 DOI: 10.1016/j.autrev.2020.102732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
165 Pfaar O, Klimek L, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen NK, Becker S, Worm M. COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA). Allergo J 2021;30:24-33. [PMID: 34393383 DOI: 10.1007/s15007-021-4846-1] [Reference Citation Analysis]
166 Cozzani E, Gasparini G, Sticchi L, Russo R, Icardi G, Parodi A. Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases. Eur J Dermatol 2021;31:415-7. [PMID: 34309530 DOI: 10.1684/ejd.2021.4043] [Reference Citation Analysis]
167 Quartuccio L, Zabotti A, Gallo T, De Vita S, Valent F. Influenza vaccination in chronic inflammatory arthritis undergoing immunosuppressive treatments: temporal trend and factors of adherence. Rheumatology (Oxford) 2021;60:2456-60. [PMID: 33083815 DOI: 10.1093/rheumatology/keaa454] [Reference Citation Analysis]
168 Aljaberi N, Ghulam E, Smitherman EA, Favier L, Dykes DMH, Danziger-Isakov LA, Brady RC, Huggins J. Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients. J Rheumatol. 2020;. [PMID: 32739895 DOI: 10.3899/jrheum.200283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
169 Vivekanantham A, Mcgagh D, Coates LC. Current treatments and recommendations for Psoriatic Arthritis. Best Practice & Research Clinical Rheumatology 2021;35:101680. [DOI: 10.1016/j.berh.2021.101680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Kiltz U, Celik A, Tsiami S, Buehring B, Baraliakos X, Andreica I, Kiefer D, Braun J. Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study. RMD Open 2021;7:e001499. [PMID: 33832974 DOI: 10.1136/rmdopen-2020-001499] [Reference Citation Analysis]
171 Ryu HJ, Han JO, Lee SA, Seo MR, Choi HJ, Ko KP, Baek HJ. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea. Rheumatology (Oxford) 2021;60:2427-33. [PMID: 33232486 DOI: 10.1093/rheumatology/keaa636] [Reference Citation Analysis]
172 Al Nokhatha S, MacEoin N, Conway R. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'. Ann Rheum Dis 2021;80:e170. [PMID: 33509797 DOI: 10.1136/annrheumdis-2021-219847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
173 Hauser SL, Kappos L, Montalban X, Craveiro L, Chognot C, Hughes R, Koendgen H, Pasquarelli N, Pradhan A, Prajapati K, Wolinsky JS. Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Neurology 2021;97:e1546-59. [PMID: 34475123 DOI: 10.1212/WNL.0000000000012700] [Reference Citation Analysis]
174 Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin (Engl Ed) 2021:S2173-5743(21)00167-2. [PMID: 34607782 DOI: 10.1016/j.reumae.2021.04.003] [Reference Citation Analysis]
175 Ekezie W, Murray RL, Agrawal S, Bogdanovica I, Britton J, Leonardi-Bee J. Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review. Clin Med (Lond) 2020;20:551-9. [PMID: 33199319 DOI: 10.7861/clinmed.2020-0359] [Reference Citation Analysis]
176 Depascale R, Del Frate G, Gasparotto M, Manfrè V, Gatto M, Iaccarino L, Quartuccio L, De Vita S, Doria A. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X211040696. [PMID: 34616495 DOI: 10.1177/1759720X211040696] [Reference Citation Analysis]
177 Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, De Leon-Ibarra AL, Galarza-Delgado DA. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Hum Vaccin Immunother 2021;17:1420-5. [PMID: 32991221 DOI: 10.1080/21645515.2020.1816108] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
178 Moretto F, Catherine FX, Esteve C, Blot M, Piroth L. Isolated Anti-HBc: Significance and Management. J Clin Med. 2020;9. [PMID: 31940817 DOI: 10.3390/jcm9010202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
179 Giannotta JA, Fattizzo B, Cavallaro F, Barcellini W. Infectious Complications in Autoimmune Hemolytic Anemia. J Clin Med 2021;10:E164. [PMID: 33466516 DOI: 10.3390/jcm10010164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
180 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]